MCGOVERN MARK E

Director at Esperion Therapeutics, Inc. · on record since Feb 28, 2014
EVP, Chief Medical Officer at KOS PHARMACEUTICALS INC · on record since Aug 12, 2005

Insider trading activity of MCGOVERN MARK E

Transactions on record: 58; since Feb 2, 2004

Open-market buys: 2; $50K

Open-market sells: 12; $12.6M

Companies traded: 2; last filing May 28, 2021

Figures computed from official regulatory filings — .

Companies where MCGOVERN MARK E has traded

Esperion Therapeutics, Inc.11 tx · $50K · May 28, 2021
KOS PHARMACEUTICALS INC47 tx · $17.7M · Dec 15, 2006

Track record of MCGOVERN MARK E

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of MCGOVERN MARK E

Co-insiders of MCGOVERN MARK E

ADAMS ADRIANKOS PHARMACEUTICALS INC
AISLING CAPITAL PARTNERS LLCEsperion Therapeutics, Inc.
Alta Partners VIII, L.P.Esperion Therapeutics, Inc.
BALDINI ROBERT EKOS PHARMACEUTICALS INC
Bartram RichardEsperion Therapeutics, Inc.
BB BIOTECH AGEsperion Therapeutics, Inc.
BELL DANIEL MKOS PHARMACEUTICALS INC
Berkowitz JeffreyEsperion Therapeutics, Inc.
BIOTECH TARGET N VEsperion Therapeutics, Inc.
BLAIR JAMES CEsperion Therapeutics, Inc.
Boxer Asset Management Inc.Esperion Therapeutics, Inc.
BRADEMAS JOHNKOS PHARMACEUTICALS INC
Braunstein ScottEsperion Therapeutics, Inc.
CARROLL J MARTINEsperion Therapeutics, Inc.
CHAMPSI FARAHEsperion Therapeutics, Inc.
Clarke Kevin PKOS PHARMACEUTICALS INC
CUBS MANAGEMENT LLCKOS PHARMACEUTICALS INC
DOMAIN PARTERS VII L PEsperion Therapeutics, Inc.
DOVEY BRIAN HEsperion Therapeutics, Inc.
DP VII ASSOCIATES LPEsperion Therapeutics, Inc.
ENRIGHT PATRICK GEsperion Therapeutics, Inc.
Ferro KevinKOS PHARMACEUTICALS INC
Fischer Seth H.Z.Esperion Therapeutics, Inc.
Foody Joanne M.Esperion Therapeutics, Inc.
Fuhrman AlanEsperion Therapeutics, Inc.
Glickman Mark AEsperion Therapeutics, Inc.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Esperion Therapeutics, Inc.	May 28, 2021	Award	12,376	0.00 USD	—	SEC
Esperion Therapeutics, Inc.	May 29, 2020	Award	6,106	0.00 USD	—	SEC
Esperion Therapeutics, Inc.	May 31, 2019	Award	4,967	0.00 USD	—	SEC
Esperion Therapeutics, Inc.	May 25, 2018	AwardD (derivative)	10,100	0.00 USD	—	SEC
Esperion Therapeutics, Inc.	Apr 19, 2017	AwardD (derivative)	14,000	0.00 USD	—	SEC
Esperion Therapeutics, Inc.	Jul 7, 2016	Buy	4,400	10.00 USD	$44K	SEC
Esperion Therapeutics, Inc.	Jul 7, 2016	Buy	600	10.00 USD	$6K	SEC
Esperion Therapeutics, Inc.	Jun 10, 2016	AwardD (derivative)	8,000	0.00 USD	—	SEC
Esperion Therapeutics, Inc.	May 18, 2015	AwardD (derivative)	8,000	0.00 USD	—	SEC
Esperion Therapeutics, Inc.	May 16, 2014	AwardD (derivative)	5,000	0.00 USD	—	SEC
Esperion Therapeutics, Inc.	Feb 28, 2014	AwardD (derivative)	20,000	0.00 USD	—	SEC
KOS PHARMACEUTICALS INC	Dec 15, 2006	OtherD (derivative)	-16,250	0.00	—	SEC
KOS PHARMACEUTICALS INC	Dec 15, 2006	OtherD (derivative)	-65,000	0.00	—	SEC
KOS PHARMACEUTICALS INC	Dec 15, 2006	OtherD (derivative)	-50,000	0.00	—	SEC
KOS PHARMACEUTICALS INC	Dec 15, 2006	OtherD (derivative)	-19,000	0.00	—	SEC
KOS PHARMACEUTICALS INC	Dec 15, 2006	Other	-14,633	78.00	$1.1M	SEC
KOS PHARMACEUTICALS INC	Mar 15, 2006	ExerciseD (derivative)	-12,500	0.00	—	SEC
KOS PHARMACEUTICALS INC	Mar 15, 2006	ExerciseD (derivative)	-16,250	0.00	—	SEC
KOS PHARMACEUTICALS INC	Mar 15, 2006	Exercise	16,250	19.50	$316.9K	SEC
KOS PHARMACEUTICALS INC	Mar 15, 2006	Sell	-16,250	49.00	$796.3K	SEC
KOS PHARMACEUTICALS INC	Mar 15, 2006	Exercise	12,500	22.55	$281.9K	SEC
KOS PHARMACEUTICALS INC	Mar 15, 2006	Sell	-12,500	49.00	$612.5K	SEC
KOS PHARMACEUTICALS INC	Jan 30, 2006	AwardD (derivative)	19,000	0.00	—	SEC
KOS PHARMACEUTICALS INC	Jan 30, 2006	Award	9,500	0.00	—	SEC
KOS PHARMACEUTICALS INC	Aug 12, 2005	Sell	-37,500	72.65 USD	$2.7M	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Esperion Therapeutics, Inc.	May 28, 2021	Award	12,376	0.00 USD	—	SEC
Esperion Therapeutics, Inc.	May 29, 2020	Award	6,106	0.00 USD	—	SEC
Esperion Therapeutics, Inc.	May 31, 2019	Award	4,967	0.00 USD	—	SEC
Esperion Therapeutics, Inc.	May 25, 2018	AwardD (derivative)	10,100	0.00 USD	—	SEC
Esperion Therapeutics, Inc.	Apr 19, 2017	AwardD (derivative)	14,000	0.00 USD	—	SEC
Esperion Therapeutics, Inc.	Jul 7, 2016	Buy	4,400	10.00 USD	$44K	SEC
Esperion Therapeutics, Inc.	Jul 7, 2016	Buy	600	10.00 USD	$6K	SEC
Esperion Therapeutics, Inc.	Jun 10, 2016	AwardD (derivative)	8,000	0.00 USD	—	SEC
Esperion Therapeutics, Inc.	May 18, 2015	AwardD (derivative)	8,000	0.00 USD	—	SEC
Esperion Therapeutics, Inc.	May 16, 2014	AwardD (derivative)	5,000	0.00 USD	—	SEC
Esperion Therapeutics, Inc.	Feb 28, 2014	AwardD (derivative)	20,000	0.00 USD	—	SEC
KOS PHARMACEUTICALS INC	Dec 15, 2006	OtherD (derivative)	-16,250	0.00	—	SEC
KOS PHARMACEUTICALS INC	Dec 15, 2006	OtherD (derivative)	-65,000	0.00	—	SEC
KOS PHARMACEUTICALS INC	Dec 15, 2006	OtherD (derivative)	-50,000	0.00	—	SEC
KOS PHARMACEUTICALS INC	Dec 15, 2006	OtherD (derivative)	-19,000	0.00	—	SEC
KOS PHARMACEUTICALS INC	Dec 15, 2006	Other	-14,633	78.00	$1.1M	SEC
KOS PHARMACEUTICALS INC	Mar 15, 2006	ExerciseD (derivative)	-12,500	0.00	—	SEC
KOS PHARMACEUTICALS INC	Mar 15, 2006	ExerciseD (derivative)	-16,250	0.00	—	SEC
KOS PHARMACEUTICALS INC	Mar 15, 2006	Exercise	16,250	19.50	$316.9K	SEC
KOS PHARMACEUTICALS INC	Mar 15, 2006	Sell	-16,250	49.00	$796.3K	SEC
KOS PHARMACEUTICALS INC	Mar 15, 2006	Exercise	12,500	22.55	$281.9K	SEC
KOS PHARMACEUTICALS INC	Mar 15, 2006	Sell	-12,500	49.00	$612.5K	SEC
KOS PHARMACEUTICALS INC	Jan 30, 2006	AwardD (derivative)	19,000	0.00	—	SEC
KOS PHARMACEUTICALS INC	Jan 30, 2006	Award	9,500	0.00	—	SEC
KOS PHARMACEUTICALS INC	Aug 12, 2005	Sell	-37,500	72.65 USD	$2.7M	SEC